Track topics on Twitter Track topics that are important to you
The FDA has accepted Avrobio's investigational new drug application for AVR-RD-04, which is indicated for the treatment of pa -More-
Today, AVROBIO welcomes newly appointed senior management leaders. http://investors.avrobio.com/news-releases/news-release-details/avrobio-inc-expands-and-strengthens-leadership-team-four-senior ...
Avrobio is set to incorporate its plato platform into its FAB-201 Phase II trial and dose patients at clinical sites...Read More... The post Avrobio to incorporate plato platform into FAB-201 Phase II...
AVROBIO, Inc. (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced that the Company will present at the Cowen and Company 39th ...
AVROBIO (NASDAQ:AVRO) a Phase 2 clinical-stage gene therapy company, today announced that its investigational gene therapy candidate for cystinosis, AVR-RD-04, is cleared to begin a Phase 1/2 clinic...
Tiburio Therapeutics has appointed Nerissa Kreher to the newly created position of chief medical officer. Kreher held that post at her previous company, Avrobio (NASDAQ: AVRO). Her experience also inc...
CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ: AVRO), (“The Company”) a Phase 2 clinical-stage gene therapy company, today announced that the Company has been sele...
CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a clinical-stage gene therapy company, today announced the appointment of Philip J. Vickers, Ph...
AVROBIO is a clinical stage company developing transformative ex-vivo gene therapies targeting cancer and rare diseases. The catalyst for creating AVROBIO is to accelerate scienti...
AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical-stage company developing disruptive therapies that have the potential to transform patientsâ lives w...
We have published hundreds of AVROBIO news stories on BioPortfolio along with dozens of AVROBIO Clinical Trials and PubMed Articles about AVROBIO for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AVROBIO Companies in our database. You can also find out about relevant AVROBIO Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...